CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 1 cited sources was verified (1 access-limited, verified via index/summary and marked), and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2028 · Search date 2026-08-03 · Methodology v0.6

Yuja tea,
does it really help with Shorter common-cold duration and milder symptoms?

30-Second Summary
?
Evidence Grade ? · Safety acceptable
No human evidence was identified that yuja tea shortens or relieves a common cold
Usual food amounts are generally well tolerated, but sweetened preserves can contain substantial sugar, so people limiting sugar should check the label.
What the
research shows
The verdict is pending. A warm yuja drink may feel soothing, but no human comparative study was found testing whether the preserve-based beverage lowers cold-symptom scores or shortens illness.
What the
ads claim
Yuja tea is generally a non-caffeinated mixture of yuja preserve, sugar, and water, but that composition fact does not establish shorter colds. No prior corpus verdict concerns the same food, so no result from another indication was substituted.
*

Useful facts when choosing a product

  • Yuja tea usually dilutes preserved yuja peel and pulp sweetened with sugar or honey; fruit and sugar content vary by product.
  • Without tea leaf or another caffeine ingredient, yuja tea is not a caffeine source; blended products require label review.
  • Donguibogam records yuja fruit under its fruit section, but that does not establish that today's sweetened yuja-tea beverage existed in 1613.
  • Reproducible search: PubMed, ClinicalTrials.gov, and Google Scholar; exact PubMed query stated above plus yuzu tea, yuja tea, and yuja-cha variants; run 2026-08-03; no eligible human beverage study identified within the search scope. Other formulas, vitamin C, and citrus extracts were excluded for intervention mismatch.
Gap Measurement · Verdict 2028 · ?
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Cold trials found in screening used Yin Qiao San, Samsoeum, vitamin C, or other plant extracts and were excluded for intervention mismatch. With no yuja-tea trial, no tea-bag dose, grams, milliliters, cups per day, primary endpoint, analyzed sample, effect size, or funding can be reported.

02

Why this is classified as ?

No human comparison measured cold symptoms or duration with this beverage, so the verdict remains unscored and pending.

Counterpoint. No evidence is not evidence of no effect. It means a treatment effect cannot currently be quantified.

Rejudgment record. Cross-check applied — Reproducible searches found no eligible human study measuring cold symptoms or duration with a yuja-preserve beverage

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal

The scoring table and the verdict agree (?).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced cold symptoms and duration?No matching beverage study was identified within the search scope.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1PubMed, ClinicalTrials.gov, and Google Scholar searchesNot applicableCold symptom score and durationNo yuja-tea beverage trial identified within the search scopeDirect basis for a pending verdict
§

Receipt — 1 References

Of 1 cited sources, 1 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-08-03.

PubMed reproducible search performed 2026-08-03: (Citrus junos[Title/Abstract] OR yuzu[Title/Abstract] OR yuja[Title/Abstract]) AND ("common cold"[Title/Abstract] OR cough[Title/Abstract] OR "sore throat"[Title/Abstract]).
partial
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Yuja tea x shorter and milder common colds Evidence Grade ? card
[Chamgap] Yuja tea x shorter and milder common colds — Evidence Grade ?. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/yuja-tea-common-cold-symptoms-duration/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.